Company Filing History:
Years Active: 2019-2025
Title: Fumihiro Sanada: Innovator in Pharmaceutical Composition
Introduction
Fumihiro Sanada is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases associated with periostin expression. With a total of 2 patents, his work is recognized for its innovative approach to addressing complex medical conditions.
Latest Patents
Sanada's latest patents include a pharmaceutical composition designed for the treatment of diseases linked to upregulated periostin expression or periostin splice variant switching. This composition comprises a nucleic acid capable of inducing skipping of exon 17 and/or exon 21 in periostin gene transcription. The invention aims to treat diseases while preserving the essential functions of periostin. Another notable patent involves an antibody against a peptide encoded by Exon-21 of periostin, which is intended for preventing or treating inflammation-associated diseases. This drug targets a periostin isoform that has cell adhesion activity, providing a novel approach to managing inflammation.
Career Highlights
Fumihiro Sanada is affiliated with Osaka University, where he conducts his research and development. His work has garnered attention for its potential impact on therapeutic strategies in the medical field.
Collaborations
Sanada collaborates with esteemed colleagues, including Yoshiaki Taniyama and Ryuichi Morishita, to advance his research and innovations in pharmaceuticals.
Conclusion
Fumihiro Sanada's contributions to pharmaceutical compositions highlight his role as an innovator in the medical field. His patents reflect a commitment to developing effective treatments for complex diseases, showcasing the importance of innovation in healthcare.